Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F J Goldstein

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Compendium (Newtown, Pa.)|June 1, 1987
Substance abuse in the health professionsF J Goldstein
American Journal of Pharmacy and the Sciences Supporting Public Health|March 1, 1971
Marijuana--a pharmacological profileF J Goldstein
The Journal of Pharmacy and Pharmacology|November 1, 1977
Central antagonism of tyramine-induced systemic hypotension by mescalineJ R Strahlendorf, F J Goldstein
Journal of Pharmaceutical Sciences|March 1, 1970
Evaluation of an improved Heidelberg telemetry capsule for the study of antacidsF J Goldstein, E W Packman
Neuropharmacology|October 1, 1979
Enhancement of morphine analgesia by tricyclic antidepressantsR T Malseed, F J Goldstein
Toxicology and Applied Pharmacology|August 1, 1973
Species variation in blood pressure responses to mescaline: evidence of histamine releaseR F Orzechowski, F J Goldstein
Life Sciences|August 1, 1974
Effect of lithium and rubidium on the ganglionic inhibitory action of norepinephrineJ B Tehrani, G V Rossi, F J Goldstein
European Journal of Pharmacology|October 1, 1972
Potentiation of monoaminergic activity in peripheral ganglia by tricyclic antidepressantsR T Malseed, G V Rossi, F J Goldstein
Neuropharmacology|January 1, 1977
Potentiation of catecholamine inhibition of ganglionic transmission by delta9-tetrahydrocannabinolF J Goldstein, E T Vernot, H K Strahlendorf
Archives Internationales De Pharmacodynamie Et De Therapie|October 1, 1982
Augmentation of central and peripheral morphine analgesia by desipramineM H Ossipov, R T Malseed, F J Goldstein
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Compendium (Newtown, Pa.)|June 1, 1987
Substance abuse in the health professionsF J Goldstein
American Journal of Pharmacy and the Sciences Supporting Public Health|March 1, 1971
Marijuana--a pharmacological profileF J Goldstein
The Journal of Pharmacy and Pharmacology|November 1, 1977
Central antagonism of tyramine-induced systemic hypotension by mescalineJ R Strahlendorf, F J Goldstein
Journal of Pharmaceutical Sciences|March 1, 1970
Evaluation of an improved Heidelberg telemetry capsule for the study of antacidsF J Goldstein, E W Packman
Neuropharmacology|October 1, 1979
Enhancement of morphine analgesia by tricyclic antidepressantsR T Malseed, F J Goldstein
Toxicology and Applied Pharmacology|August 1, 1973
Species variation in blood pressure responses to mescaline: evidence of histamine releaseR F Orzechowski, F J Goldstein
Life Sciences|August 1, 1974
Effect of lithium and rubidium on the ganglionic inhibitory action of norepinephrineJ B Tehrani, G V Rossi, F J Goldstein
European Journal of Pharmacology|October 1, 1972
Potentiation of monoaminergic activity in peripheral ganglia by tricyclic antidepressantsR T Malseed, G V Rossi, F J Goldstein
Neuropharmacology|January 1, 1977
Potentiation of catecholamine inhibition of ganglionic transmission by delta9-tetrahydrocannabinolF J Goldstein, E T Vernot, H K Strahlendorf
Archives Internationales De Pharmacodynamie Et De Therapie|October 1, 1982
Augmentation of central and peripheral morphine analgesia by desipramineM H Ossipov, R T Malseed, F J Goldstein
Pageof 3